Glyburide
79 interactions 4 explained in plain EnglishGlyburide is a sulfonylurea medication that lowers blood sugar in people with type 2 diabetes. Read the full Glyburide drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Glyburide Acarbose Prandase® Explained An increased risk of hypoglycemia Details Glyburide Asciminib Scemblix Increased CYP2C9 substrate exposure and an increased risk of CYP2C9 substrate-related adverse reactions Details Glyburide Belumosudil Rezurock Explained Increased OATP1B1 substrate exposure Details Glyburide Abiraterone Abirtega An increased risk of severe hypoglycemia Details Glyburide Capecitabine Xeloda Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Glyburide Chloroquine Aralen® Hypoglycemia Details Glyburide Darolutamide Nubeqa Increased exposure of OATP1B1 or OATP1B3 substrates Details Glyburide Delafloxacin Baxdela Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Delafloxacin Injection Baxdela Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Disopyramide Norpace Increased risk of hypoglycemia Details Glyburide Dulaglutide Injection Trulicity Increased risk of hypoglycemia Details Glyburide Enasidenib Idhifa Increased glyBURIDE exposure and an increased risk of glyBURIDE-related adverse effects Details Glyburide Entacapone Comtan Increased exposure of CYP2C9 substrate Details Glyburide Fluorouracil Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Glyburide Fluorouracil Injection Adrucil Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Glyburide Fluorouracil Topical Carac Increased exposure of CYP2C9 substrates and an increased risk of CYP2C9 substrates-related adverse effects Details Glyburide Furosemide Injection Disal An increased risk of hyperglycemia and an increased insulin requirement Details Glyburide Gatifloxacin Ophthalmic Zymar® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Gemifloxacin Factive Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Hydroxychloroquine Plaquenil Enhanced hypoglycemic effect of antidiabetics and an increased risk of hypoglycemia Details Glyburide Insulin Degludec (Rdna Origin) Injection Ryzodeg® (as a combination product containing Insulin Degludec and Insulin Aspart) An increased risk of hypoglycemia Details Glyburide Insulin Detemir (Rdna Origin) Injection Levemir An increased risk of hypoglycemia Details Glyburide Insulin Glulisine (Rdna Origin) Injection Apidra An increased risk of hypoglycemia Details Glyburide Lanreotide Injection Somatuline An increased risk of hypoglycemia and impaired glucose regulation Details Glyburide Leflunomide Arava Increased exposure of OATP1B1/1B3 substrate Details Glyburide Leniolisib Joenja Increased OATP1B1/OATP1B3 substrate exposure Details Glyburide Letermovir Injection Prevymis Increased glyBURIDE exposure Details Glyburide Levofloxacin Levaquin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Levofloxacin Injection Levaquin Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Lixisenatide Injection Adlyxin® Increased risk of hypoglycemia Details Glyburide Methotrexate Jylamvo Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Glyburide Methotrexate Injection Abitrexate® Increased methotrexate exposure, an increased risk of methotrexate-related severe adverse reactions, reduced active metabolite for... Details Glyburide Midostaurin Rydapt Increased OATP1B1 substrate exposure Details Glyburide Moxifloxacin Avelox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Moxifloxacin Injection Avelox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Moxifloxacin Ophthalmic Moxeza® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Octreotide Bynfezia An increased risk of hypoglycemia and impaired glucose regulation Details Glyburide Octreotide Injection Bynfezia An increased risk of hypoglycemia and impaired glucose regulation Details Glyburide Ofloxacin Floxin® Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Glyburide Ofloxacin Ophthalmic Ocuflox Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist